Catalytic nanomedicine: a brief review of bionanocatalysts
TM López-Goerne, FJ Padilla-Godínez… - …, 2022 - Taylor & Francis
Catalytic nanomedicine is a research area and source of disruptive technology that studies
the application of bionanocatalysts (organically functionalized mesoporous nanostructured …
the application of bionanocatalysts (organically functionalized mesoporous nanostructured …
Network pharmacology-based analysis for unraveling potential cancer-related molecular targets of Egyptian propolis phytoconstituents accompanied with molecular …
RS Ibrahim, AA El-Banna - RSC advances, 2021 - pubs.rsc.org
Cancer is one of the predominant causes of death worldwide. The new trend nowadays is to
exploit natural products with the hope of developing new anticancer agents with fewer side …
exploit natural products with the hope of developing new anticancer agents with fewer side …
Catalytic Nanomedicine as a Therapeutic Approach to Brain tumors: Main hypotheses for mechanisms of action
T López-Goerne, FJ Padilla-Godínez - Nanomaterials, 2023 - mdpi.com
Glioblastoma multiforme (GBM) is the most aggressive primary malignant tumor of the brain.
Although there are currently a wide variety of therapeutic approaches focused on tumor …
Although there are currently a wide variety of therapeutic approaches focused on tumor …
Andrographis echioides mediated synthesis of ZnONPs: A mechanistic insight into their antibacterial and anticancer efficacy
T Hema, M Velumani, G Thiruppathi… - Inorganic Chemistry …, 2024 - Elsevier
Finding alternatives to traditional antibiotics has become crucial due to the emerging
antibiotic resistance shown by various microorganisms. Metal nanoparticles are arising as …
antibiotic resistance shown by various microorganisms. Metal nanoparticles are arising as …
Chitosan stabilized platinum nanoparticles: Synthesis, characterization and cytotoxic impacts on human breast cancer cells
Platinum nanoparticles are widely studied as a nanomedicine against many of the solid
tumours. Due to their promising physicochemical properties, chitosan-stabilized platinum …
tumours. Due to their promising physicochemical properties, chitosan-stabilized platinum …
Revolutionizing Drug Removal: Green Magnetic Nanoparticles Functionalized with Hydrophobic Deep Eutectic Solvents for Anti-Inflammatory Drug Adsorption
Non-steroidal anti-inflammatory medications are popular pharmaceutical and personal
products due to their anti-inflammatory properties and ease of availability. However, the …
products due to their anti-inflammatory properties and ease of availability. However, the …
Poly (lactic-co-glycolic acid) encapsulated platinum nanoparticles for cancer treatment
Metal nanoparticles have been of interest to the field of nanomedicine due to their potential
for cancer treatment, diagnosis, and antimicrobial activity. Particularly, platinum …
for cancer treatment, diagnosis, and antimicrobial activity. Particularly, platinum …
Phototoxic potential of different DNA intercalators for skin cancer therapy: In vitro screening
Photodynamic therapy is a minimally invasive procedure used in the treatment of several
diseases, including some types of cancer. It is based on photosensitizer molecules, which, in …
diseases, including some types of cancer. It is based on photosensitizer molecules, which, in …
Cytotoxic Cu (II) Complexes with a Novel Quinoline Derivative Ligand: Synthesis, Molecular Docking, and Biological Activity Analysis
The utilization of metallodrugs as a viable alternative to organic molecules has gained
significant attention in modern medicine. We hereby report synthesis of new imine quinoline …
significant attention in modern medicine. We hereby report synthesis of new imine quinoline …
[HTML][HTML] The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer
D Han, JM Spehar, DS Richardson, S Leelananda… - Cancers, 2024 - mdpi.com
Simple Summary Here, we demonstrate an essential role for the RAS downstream effectors
RALA and RALB in TNBC and describe a promising novel small molecule RAL inhibitor. We …
RALA and RALB in TNBC and describe a promising novel small molecule RAL inhibitor. We …